Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

146.74
Delayed Data
As of Aug 22
 +4.12 / +2.89%
Today’s Change
95.80
Today|||52-Week Range
163.75
+34.59%
Year-to-Date
Ironwood Pharma's Combination Gout Drug Gets FDA Approval
Aug 22 / Zacks.com - Paid Partner Content
Endo International (ENDP) Jumps: Stock Rises 6.9%
Aug 17 / Zacks.com - Paid Partner Content
Rally Set to Resume: Buy These 5 Value Picks on the Dip
Aug 22 / Zacks.com - Paid Partner Content
Jounce Therapeutics (JNCE) Jumps: Stock Moves 7.4% Higher
Aug 17 / Zacks.com - Paid Partner Content
Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer
Aug 18 / Zacks.com - Paid Partner Content
Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact
Aug 09 / Zacks.com - Paid Partner Content
Biotech Movers: Jazz Shares Lower Amid Notes Offering
Aug 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close142.62
Today’s open143.27
Day’s range143.27 - 147.54
Volume784,940
Average volume (3 months)464,864
Market cap$8.6B
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)+22.56%
Earnings growth (this year)+7.15%
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+12.32%
P/E ratio22.6
Price/Sales4.53
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.63-1.24%
ALNYAlnylam Pharmaceutic...+1.12+1.32%
SGENSeattle Genetics Inc+1.30+2.81%
TSROTESARO Inc+1.76+1.48%
Data as of 08/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$2.91
Annual revenue (last year)$1.5B
Annual profit (last year)$396.8M
Net profit margin26.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts